beta-thalassemia

First gene therapy to treat rare blood disease nears European approval
First gene therapy to treat rare blood disease nears European approval
Stat
Bluebird Bio
Europe
LentiGlobin
gene therapy
beta-thalassemia
Flag link:
Bluebird’s gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
Bluebird’s gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
Endpoints
Bluebird Bio
beta-thalassemia
gene therapy
Flag link:
Bluebird Reports Early Results From Upgraded Gene Therapy
Bluebird Reports Early Results From Upgraded Gene Therapy
Xconomy
Bluebird Bio
LentiGlobin
gene therapy
clinical trials
beta-thalassemia
Flag link:
Sangamo to transfer two gene therapies to Biogen spin-off
Sangamo to transfer two gene therapies to Biogen spin-off
BioPharma Dive
Sangamo
gene therapy
Biogen
Bioverativ
sickle cell disease
beta-thalassemia
Flag link:
Bluebird Shares Plunge on Waning Effect of Old Gene Therapy
Bluebird Shares Plunge on Waning Effect of Old Gene Therapy
TheStreet.com
Bluebird Bio
gene therapy
beta-thalassemia
Flag link:
3 Clinical Trials to Watch As Bluebird Bio Rounds Out 2015
3 Clinical Trials to Watch As Bluebird Bio Rounds Out 2015
Motley Fool
clinical trials
Bluebird Bio
HGB-205
HGB-206
HGB-204
sickle cell disease
beta-thalassemia
Flag link:
What's in bluebird bio's Pipeline That Has Investors So Excited?
What's in bluebird bio's Pipeline That Has Investors So Excited?
Motley Fool
Bluebird Bio
gene therapy
LentiGlobin
beta-thalassemia
sickle cell disease
Flag link:
A pair of Celgene partners gets on the FDA fast track
A pair of Celgene partners gets on the FDA fast track
Fierce Biotech
Celgene
FDA
fast track
luspatercept
Acceleron
beta-thalassemia
AG-120
Agios Pharmaceuticals
Flag link:
Gene therapy pioneer Bluebird bags a 'breakthrough' title for lead program
Gene therapy pioneer Bluebird bags a 'breakthrough' title for lead program
Fierce Biotech
Bluebird Bio
gene therapy
beta-thalassemia
LentiGlobin BB305
Flag link:
Bluebird Stock Rockets On Gene Therapy Results
Bluebird Stock Rockets On Gene Therapy Results
Forbes
Bluebird Bio
beta-thalassemia
Flag link:
Biogen to Develop Blood Medicines in Deal With Sangamo
Biogen to Develop Blood Medicines in Deal With Sangamo
Bloomberg
Biogen Idec
Sangamo BioSciences
beta-thalassemia
sickle cell disease
Flag link:
Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic for Beta-thalassemia
Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic for Beta-thalassemia
Yahoo/PR NewsWire
Sangamo BioSciences
beta-thalassemia
stem cells
ZFP Therapeutic
Flag link:
Acceleron Receives Two FDA Orphan Designations for ACE-536
Acceleron Receives Two FDA Orphan Designations for ACE-536
Yahoo
FDA
orphan drugs
ACE-536
Acceleron
beta-thalassemia
myelodysplastic syndromes
Flag link: